KLK18: A Potential Drug Target for Tissue Growth and Development

Target Name: KRT18P12

NCBI ID: G643471

KRT18P12

Other Name(s): keratin 18 pseudogene 12 | Keratin 18 pseudogene 12

KLK18: A Potential Drug Target for Tissue Growth and Development

KRT18P12 is a gene that encodes for a protein known as kallikrein-related protein 18 (KLK18) or Keratin 18. This protein is a type of cytoskeletal protein that is expressed in various tissues throughout the body, including the skin, hair, nails, and nails. It plays a role in the structure and function of these tissues, and is also involved in several cellular processes that are important for tissue growth and development.

One of the things that makes KLK18 a potential drug target is its role in the regulation of cell growth. In cancer cells, KLK18 is expressed at high levels and is involved in the development of a cancerous phenotype. Studies have shown that inhibiting KLK18 can lead to a reduction in the growth and spread of cancer cells.

Another potential drug target for KLK18 is its role in the regulation of cell death. In situations where cells are facing stress or damage, KLK18 is involved in the process of apoptosis, which is the natural way for cells to self-destruct. By activating the apoptosis pathway, KLK18 helps to ensure that damaged cells are eliminated, which can be useful in treating diseases where cells can become too much and cause problems.

In addition to its role in cell growth and apoptosis, KLK18 is also involved in several other cellular processes that are important for normal tissue development and function. For example, it is involved in the regulation of cell division, and is thought to play a role in the development of certain types of cancer. It is also involved in the regulation of the cytoskeleton, which is the structure that gives cells their shape and helps them to move and function.

Given its involvement in so many important cellular processes, KLK18 is a promising target for drug development. Researchers are currently working to identify small molecules that can inhibit the activity of KLK18 and use them to develop new treatments for a variety of diseases. These treatments may include drugs that target specific compounds within the KLK18 pathway, as well as those that target KLK18 itself directly.

In conclusion, KRT18P12 is a gene that encodes for a protein that is involved in a variety of cellular processes that are important for normal tissue development and function. Its potential as a drug target makes it an attractive target for research into the treatment of a wide range of diseases. As research continues, it is likely that the full potential of KLK18 will be discovered, and new treatments will be developed that can help to improve the health and well-being of people around the world.

Protein Name: Keratin 18 Pseudogene 12

The "KRT18P12 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KRT18P12 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets